"Leprostatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that suppress Mycobacterium leprae, ameliorate the clinical manifestations of leprosy, and/or reduce the incidence and severity of leprous reactions.
| Descriptor ID |
D007917
|
| MeSH Number(s) |
D27.505.954.122.085.777
|
| Concept/Terms |
Leprostatic Agents- Leprostatic Agents
- Agents, Leprostatic
- Leprostatics
- Antileprotic Agents
- Agents, Antileprotic
|
Below are MeSH descriptors whose meaning is more general than "Leprostatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Leprostatic Agents".
This graph shows the total number of publications written about "Leprostatic Agents" by people in this website by year, and whether "Leprostatic Agents" was a major or minor topic of these publications.
Below are the most recent publications written about "Leprostatic Agents" by people in Profiles.
-
Leprosy-Insufficient Evidence for Monthly Multidrug Therapy. JAMA Dermatol. 2024 Jul 01; 160(7):785.
-
Lucio phenomenon with concomitant necrotizing fasciitis and acute kidney injury. Dermatol Online J. 2022 Jun 15; 28(3).
-
Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19). Rev Cardiovasc Med. 2020 12 30; 21(4):517-530.
-
Building Optimal Three-Drug Combination Chemotherapy Regimens. Antimicrob Agents Chemother. 2020 10 20; 64(11).
-
Psoriasiform Pemphigus Foliaceus in an African American Female: An Important Clinical Manifestation. J Drugs Dermatol. 2018 Apr 01; 17(4):471-473.
-
Dapsone-associated fixed drug eruption. Expert Rev Clin Pharmacol. 2017 Jul; 10(7):717-725.
-
pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion. Pharm Res. 2015 Aug; 32(8):2516-26.
-
Recognizing and managing the immunologic reactions in leprosy. J Am Acad Dermatol. 2014 Oct; 71(4):795-803.
-
HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med. 2013 Oct 24; 369(17):1620-8.
-
Epidemiological trends of leprosy in an urban leprosy centre of Delhi: a retrospective study of 16 years. Indian J Lepr. 2011 Oct-Dec; 83(4):201-8.